Evidence map›Paper›PMID 32673237›Full record

Trial reportJMIR mHealth and uHealth2020

Users' Experiences of a Mobile Health Self-Management Approach for the Treatment of Cystic Fibrosis: Mixed Methods Study.

Jacqueline Floch, Thomas Vilarinho, Annabel Zettl, Gema Ibanez-Sanchez, Joaquim Calvo-Lerma, Erlend Stav, Peter Halland Haro, Asbjørn Lein Aalberg, Alvaro Fides-Valero, José Luis Bayo Montón

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in JMIR mHealth and uHealth, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jacqueline FlochSINTEF, Trondheim, Norway.ORCID 0000-0003-4939-586X
Thomas VilarinhoSINTEF, Trondheim, Norway.ORCID 0000-0002-7076-7835
Annabel ZettlYOUSE GmbH, München, Germany.ORCID 0000-0003-1939-1630
Gema Ibanez-SanchezUniversitat Politècnica de València, València, Spain.ORCID 0000-0003-1824-281X
Joaquim Calvo-LermaUniversitat Politècnica de València, València, Spain.ORCID 0000-0001-7818-0652
Erlend StavSINTEF, Trondheim, Norway.ORCID 0000-0001-9957-6744
Peter Halland HaroSINTEF, Trondheim, Norway.ORCID 0000-0003-1918-9280
Asbjørn Lein AalbergSINTEF, Trondheim, Norway.ORCID 0000-0003-4871-2739
Alvaro Fides-ValeroUniversitat Politècnica de València, València, Spain.ORCID 0000-0002-7299-576X
José Luis Bayo MontónUniversitat Politècnica de València, València, Spain.ORCID 0000-0003-2602-6367
SINTEF · NOUniversitat Politècnica de València · ESInstituto de Investigación Sanitaria La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite a large number of clinical trials aiming at evaluating the digital self-management of chronic diseases, there is little discussion about users' experiences with digital approaches. However, a good user experience is a critical factor for technology adoption. Understanding users' experiences can inform the design of approaches toward increased motivation for digital self-management.

objectiveThis study aimed to evaluate the self-management of cystic fibrosis (CF) with a focus on gastrointestinal concerns and the care of young patients. Following a user-centered design approach, we developed a self-management app for patients and parents and a web tool for health care professionals (HCPs). To evaluate the proposed solutions, a 6-month clinical trial was conducted in 6 European CF competence centers. This paper analyzes the user acceptance of the technology and the benefits and disadvantages perceived by the trial participants.

methodsA mixed methods approach was applied. Data were collected through 41 semistructured qualitative interviews of patients, parents, and HCPs involved in the clinical trial. In addition, data were collected through questionnaires embedded in the self-management app.

resultsSupport for enzyme dose calculation and nutrition management was found to be particularly useful. Patients and parents rapidly strengthened their knowledge about the treatment and increased their self-efficacy. Reported benefits include reduced occurrence of symptoms and enhanced quality of life. Patients and parents had different skills, requiring follow-up by HCPs in an introductory phase. HCPs valued obtaining precise information about the patients, allowing for more personalized advice. However, the tight follow-up of several patients led to an increased workload. Over time, as patient self-efficacy increased, patient motivation for using the app decreased and the quality of the reported data was reduced.

conclusionsSelf-management enfolds a collaboration between patients and HCPs. To be successful, a self-management approach should be accepted by both parties. Through understanding behaviors and experiences, this study defines recommendations for a complex case-the demanding treatment of CF. We identify target patient groups and situations for which the app is most beneficial and suggest focusing on these rather than motivating for regular app usage over a long time. We also advise the personalized supervision of patients during the introduction of the approach. Finally, we propose to develop guidance for HCPs to facilitate changes in practice. As personalization and technology literacy are factors found to influence the acceptance of digital self-management of other chronic diseases, it is relevant to consider the proposed recommendations beyond the case of CF.

Indexed as

Cystic FibrosisSelf-ManagementTelemedicineHumansMobile ApplicationsPatient SatisfactionQualitative ResearchSurveys and Questionnairescystic fibrosismHealthmixed methods studymobile healthpediatricsself-managementuser acceptanceuser experience

Identifiers

PMID32673237
PMCPMC7381063
OpenAlexW3022245921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.